Caspofungin 50mg InjectionInjection
Anti-Fungal

Caspofungin 50mg Injection

Caspofungin Acetate

First-in-class echinocandin antifungal that inhibits beta-1,3-D-glucan synthesis in fungal cell walls, providing fungicidal activity against Candida species and fungistatic activity against Aspergillus without cross-resistance to azoles or polyenes. Manufactured by Cipla and Glenmark for hospital ICU formulary export.

Strengths

50mg / 70mg

Packing

1 vial/box

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Caspofungin Acetate 50mg / 70mg lyophilized powder for infusion
Dosage Form
Injection
Available Strengths
50mg / 70mg
Packing
1 vial/box
Route of Administration
Intravenous infusion over approximately 1 hour
Dosage
Loading dose: 70mg IV on day 1; Maintenance: 50mg IV once daily
Indications
Invasive candidiasis, empirical therapy for presumed fungal infections in febrile neutropenia, invasive aspergillosis (salvage therapy), esophageal candidiasis
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 2-8°C
Shelf Life
24 months
Side Effects
Fever, infusion site reactions, nausea, elevated liver enzymes, headache, rash, hypokalemia, phlebitis
Precautions
Dose reduction to 35mg in moderate hepatic impairment; not effective against Cryptococcus; histamine-related reactions possible; monitor liver function; limited CNS penetration

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Caspofungin 50mg Injection?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote